Abnormal regulation of the oestrogen receptor in benign breast lesions

Journal of Clinical Pathology

Volumn 53, Issue 10, 2000, Pages 778-783

  Shoker, B S ^a   Jarvis, C ^a   Clarke, R B ^b   Andersen, E ^b   Munro, C ^a   Davies, M P A ^c   Sibson, D R ^c   Sloane, J P ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c CLATTERBRIDGE HOSPITAL   (United Kingdom)

Author keywords

Benign breast; Oestrogen receptor; Precancerous breast; Proliferation

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN;

ARTICLE; BREAST CANCER; BREAST DISEASE; BREAST DUCT ECTASIA; BREAST FIBROADENOMA; BREAST PAPILLOMA; CANCER RISK; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTOSARCOMA PHYLLOIDES; DISEASE ASSOCIATION; GYNECOMASTIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LACTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TISSUE DISTRIBUTION;

ADULT; AGED; AGING; BREAST; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GYNECOMASTIA; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; RECEPTORS, ESTROGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0033779476     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.53.10.778     Document Type: Article

References (21)

1. 1 Howell A. Clinical evidence for the involvement of oestrogen in the development and progression of breast cancer. Proceeding of the Royal Society of Edinburgh 1989;95B:49-57.
2. 2 Kelsey JL, Gammon MD, John EM. Reproductive and hormonal risk factors: reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
3. 3 Clarke RB, Howell A, Potten CS, et al. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 1997;57:4987-91.
4. 4 Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51.
5. 5 Carter CL, Corle DK, Micozzi MS, et al. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 1988;128:467-77.
6. 6 London SJ, Connolly JL, Schnitt SJ, et al. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992;267:941-4.
7. 7 Bodian CA, Perzin KH, Lattes R, et al. Prognostic significance of benign proliferative breast disease. Cancer 1993;71:3896-907.
8. 8 Shoker BS, Jarvis C, Sibson DR, et al. Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol 1999;188:237-44.
9. 9 Shoker BS, Jarvis C, Clarke RB, et al. Oestrogen receptor-positive proliferating cells in the normal and precancerous breast. Am J Pathol 1999;155:1811-15.
10. 10 Jensen RA, Page DL, Dupont WD, et al. Invasive breast cancer risk in women with sclerosing adenosis. Cancer 1989;64:1977-83.
11. 11 Page DL, Salhany KE, Jensen RA, et al. Subsequent breast carcinoma after biopsy with atypia in a breast papilloma. Cancer 1996;78:258-66.
12. 12 Sloane JP, Mayers MM. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions - importance of lesion size and patient age. Histopathology 1993;23:225-31.
13. 13 Douglas-Jones AG, Pace DP. Pathology of R4 spiculated lesions in the breast screening programme. Histopathology 1997;30:214-20.
14. 14 Jacobs TW, Byrne C, Colditz G, et al. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 1999;340:430-6.
15. 15 Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 1994;331:10-15.
16. 16 McDivitt RW, Stevens JA, Lee NC, et al. Histologic types of benign breast disease and the risk for breast cancer. Cancer 1992;69:1408-14.
17. 17 National co-ordinating group for breast screening pathology. Pathology reporting in breast cancer screening, 2nd ed. NHSBSP publication no. 3, Sheffield: KHSBSP Publications, 1997:1-65.
18. 18 Zelada-Hedman M, Werer G, Collins P, et al. High expression of the EGFR in fibroadenomas compared to breast carcinomas. Anticancer Res 1994;14:1679-88.
19. 19 Stratton MR, Collins N, Lakhani SR, et al. Loss of heterozygosiry in ductal carcinoma in situ of the breast. J Pathol 1995;175:195-201.
20. 20 Lakhani SR, Collins N, Stratton MR, et al. Aypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 1995;48:611-15.
21. 21 Lakhani SR, Slack DN, Hamoudi RA, et al. Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lab Invest 1996;74:129-35.